Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
LUM Imaging System
COMBINATION_PRODUCT
6 trials
Sponsors
Lumicell, Inc.
Conditions
Breast Cancer
Glioblastoma
Low Grade Glioma of Brain
Metastasis to Brain
Neoadjuvant Therapy
Neoplasm, Residual
Pancreatic Cancer
Peritoneal Metastases
+1 more
Phase 1
Feasibility of the LUM Imaging System for Detection of Prostate Cancer
Terminated
NCT03441464
Lumicell, Inc.
Neoplasm, Residual, Prostate Cancer
Start: 2019-03-20
End: 2021-02-11
Updated: 2022-02-25
Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies
Completed
NCT03834272
Lumicell, Inc.
Peritoneal Metastases
Start: 2019-03-18
End: 2025-08-19
Updated: 2026-01-16
Phase 2
Intraoperative Detection of Residual Cancer in Breast Cancer
Completed
NCT03321929
Lumicell, Inc.
Breast Cancer
Start: 2018-02-06
End: 2020-04-10
Updated: 2023-05-01
Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients
Terminated
NCT04440982
Lumicell, Inc.
Breast Cancer, Neoadjuvant Therapy
Start: 2020-09-01
End: 2024-02-29
Updated: 2025-01-15
Unknown Phase
Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
Terminated
NCT03717142
Lumicell, Inc.
Glioblastoma, Low Grade Glioma of Brain, Metastasis to Brain
Start: 2019-05-03
End: 2024-06-14
Updated: 2025-01-15
Feasibility Study of LUM Imaging System for Pancreatic Cancer
Withdrawn
NCT04276909
Lumicell, Inc.
Pancreatic Cancer
Start: 2026-01-31
End: 2026-01-31
Updated: 2024-03-13
Related Papers
Abstract PS5-07-13: Impact of pegulicianine on radiotherapy decisions and long-term outcomes in patients undergoing breast conserving surgery
Clinical Cancer Research
2026-02-17
Abstract CT043: Feasibility study to evaluate performance of the LUM Imaging System for intraoperative detection of residual tumor in breast cancer patients receiving and not receiving neoadjuvant therapy
Cancer Research
2023-04-14
Abstract OT2-07-01: Feasibility study to evaluate performance of the LUM Imaging System for intraoperative detection of residual tumor in breast cancer patients receiving and not receiving neoadjuvant therapy
Cancer Research
2023-03-01
Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence–Guided System
JAMA Surgery
2022-05-11
38 citations
Abstract OT2-12-02: Feasibility study to evaluate performance of the LUM imaging system for intraoperative detection of residual tumor in patients with breast cancer receiving neoadjuvant therapy
Cancer Research
2022-02-15
Abstract CT245: Feasibility study to evaluate performance of the Lum Imaging System for intraoperative detection of residual tumor in patients with breast cancer receiving neoadjuvant therapy
Cancer Research
2021-07-01
Abstract P1-20-06: Results from the expansion into multiple institutions for training in the use of the LUM imaging system for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer clinical trial
Cancer Research
2020-02-15
1 citations
Abstract OT3-06-02: Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer
Cancer Research
2020-02-15
Abstract CT220: Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer
Cancer Research
2019-07-01
Abstract CT220: Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer
Clinical Trials
2019-07-01